Page last updated: 2024-10-21

3,4-methylenedioxyamphetamine and Retinal Detachment

3,4-methylenedioxyamphetamine has been researched along with Retinal Detachment in 1 studies

3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.

Retinal Detachment: Separation of the inner layers of the retina (neural retina) from the pigment epithelium. Retinal detachment occurs more commonly in men than in women, in eyes with degenerative myopia, in aging and in aphakia. It may occur after an uncomplicated cataract extraction, but it is seen more often if vitreous humor has been lost during surgery. (Dorland, 27th ed; Newell, Ophthalmology: Principles and Concepts, 7th ed, p310-12).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Seamone, ME1
Choudhry, N1
Kapusta, M1
Baig, K1
Chen, J1
Galic, J1
Gupta, RR1
Gupta, R1

Other Studies

1 other study available for 3,4-methylenedioxyamphetamine and Retinal Detachment

ArticleYear
Eye love you.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2016, Volume: 51, Issue:1

    Topics: Endothelium, Corneal; Eye Foreign Bodies; Eye Infections, Fungal; Geographic Atrophy; Heart; Humans;

2016